443 related articles for article (PubMed ID: 32786368)
1. Dendrimers toward Translational Nanotherapeutics: Concise Key Step Analysis.
Mignani S; Shi X; Rodrigues J; Roy R; Muñoz-Fernández Á; Ceña V; Majoral JP
Bioconjug Chem; 2020 Sep; 31(9):2060-2071. PubMed ID: 32786368
[TBL] [Abstract][Full Text] [Related]
2. Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles.
Lanza GM; Winter PM; Caruthers SD; Hughes MS; Cyrus T; Marsh JN; Neubauer AM; Partlow KC; Wickline SA
Nanomedicine (Lond); 2006 Oct; 1(3):321-9. PubMed ID: 17716162
[TBL] [Abstract][Full Text] [Related]
3. Why I believe nanoparticles are crucial as a carrier for targeted drug delivery.
Baker JR
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):423-9. PubMed ID: 23633301
[TBL] [Abstract][Full Text] [Related]
4. Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers.
Moritz M; Geszke-Moritz M
Adv Clin Exp Med; 2015; 24(5):749-58. PubMed ID: 26768624
[TBL] [Abstract][Full Text] [Related]
5. Targeted nanosystems: Advances in targeted dendrimers for cancer therapy.
Yang H
Nanomedicine; 2016 Feb; 12(2):309-16. PubMed ID: 26706410
[TBL] [Abstract][Full Text] [Related]
6. Ocular drug delivery: nanomedicine applications.
Vandervoort J; Ludwig A
Nanomedicine (Lond); 2007 Feb; 2(1):11-21. PubMed ID: 17716187
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of dendrimers and drug-dendrimer conjugates for drug delivery.
Najlah M; D'Emanuele A
Curr Opin Drug Discov Devel; 2007 Nov; 10(6):756-67. PubMed ID: 17987527
[TBL] [Abstract][Full Text] [Related]
8. Dendrimers in the context of nanomedicine.
Dias AP; da Silva Santos S; da Silva JV; Parise-Filho R; Igne Ferreira E; Seoud OE; Giarolla J
Int J Pharm; 2020 Jan; 573():118814. PubMed ID: 31759101
[TBL] [Abstract][Full Text] [Related]
9. Dendrimer-nanoparticle conjugates in nanomedicine.
Parat A; Bordeianu C; Dib H; Garofalo A; Walter A; Bégin-Colin S; Felder-Flesch D
Nanomedicine (Lond); 2015; 10(6):977-92. PubMed ID: 25867861
[TBL] [Abstract][Full Text] [Related]
10. Role of nanotechnology in developing new therapies for diseases of the nervous system.
Jain KK
Nanomedicine (Lond); 2006 Jun; 1(1):9-12. PubMed ID: 17716203
[No Abstract] [Full Text] [Related]
11. Multivalency in Drug Delivery-When Is It Too Much of a Good Thing?
Tjandra KC; Thordarson P
Bioconjug Chem; 2019 Mar; 30(3):503-514. PubMed ID: 30742420
[TBL] [Abstract][Full Text] [Related]
12. Mesoporous silica nanoparticles as nanocarriers.
Wu SH; Hung Y; Mou CY
Chem Commun (Camb); 2011 Sep; 47(36):9972-85. PubMed ID: 21716992
[TBL] [Abstract][Full Text] [Related]
13. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W
Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450
[TBL] [Abstract][Full Text] [Related]
14. Recent trends of nanomedicinal approaches in clinics.
Dilnawaz F; Acharya S; Sahoo SK
Int J Pharm; 2018 Mar; 538(1-2):263-278. PubMed ID: 29339248
[TBL] [Abstract][Full Text] [Related]
15. Tiny technology proves big: a challenge at engineering, medicine and pharmaceutical sciences interface.
Mahapatra AK; Murthy PN; Samoju S; Mohapatra AK
Crit Rev Ther Drug Carrier Syst; 2014; 31(1):1-47. PubMed ID: 24579766
[TBL] [Abstract][Full Text] [Related]
16. Current progress in nanotechnology applications for diagnosis and treatment of kidney diseases.
Lee SH; Lee JB; Bae MS; Balikov DA; Hwang A; Boire TC; Kwon IK; Sung HJ; Yang JW
Adv Healthc Mater; 2015 Sep; 4(13):2037-45. PubMed ID: 26121684
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; Grazú V; Borm P; Estrada G; Ntziachristos V; Razansky D
Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
[TBL] [Abstract][Full Text] [Related]
18. Recent progress in dendrimer-based nanomedicine development.
Kim Y; Park EJ; Na DH
Arch Pharm Res; 2018 Jun; 41(6):571-582. PubMed ID: 29450862
[TBL] [Abstract][Full Text] [Related]
19. Nano based drug delivery systems: recent developments and future prospects.
Patra JK; Das G; Fraceto LF; Campos EVR; Rodriguez-Torres MDP; Acosta-Torres LS; Diaz-Torres LA; Grillo R; Swamy MK; Sharma S; Habtemariam S; Shin HS
J Nanobiotechnology; 2018 Sep; 16(1):71. PubMed ID: 30231877
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers.
Aghebati-Maleki A; Dolati S; Ahmadi M; Baghbanzhadeh A; Asadi M; Fotouhi A; Yousefi M; Aghebati-Maleki L
J Cell Physiol; 2020 Mar; 235(3):1962-1972. PubMed ID: 31441032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
